Is It Worth Your Time and Money To Set Up an HSA?
LISTEN: Is it worth it to set up a health savings account? HealthQ has answers….
Is It Worth Your Time and Money To Set Up an HSA?
LISTEN: Is it worth it to set up a health savings account? HealthQ has answers. When Mike McKee thinks about saving money for the future, he has a few priorities. Maxing out his retirement is one. Building up his kid’s college fund is another. Opening up a health savings account? Not so much, even though…
In Switching to Original Medicare, Beware of Medigap Plan Refusals
It’s open enrollment season for Medicare Advantage, when people currently enrolled in private managed-care plans can either sign up for a new one or switch to original Medicare through March 31. But there’s a catch: If people want to move to original Medicare and buy a supplemental Medigap insurance plan to cover some out-of-pocket costs,…
Reckoning With State and Federal Cuts, Los Angeles Safety-Net Clinics Push for a New Tax
LOS ANGELES — Mia Angulo, who is pregnant and due in May, is living in a tent with her boyfriend in the predominantly Latino neighborhood of Boyle Heights. Lingering pain from a car crash two months ago, on top of an already hardscrabble life, has Angulo worried about her pregnancy. So, she was relieved when…
At SXSW, Cuban and eMed CEO Draw Contrast Between Them and Other “Marketing” Companies
Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of the employer GLP-1 platform eMed Population Health, were at SXSW drawing a contrast between their approach to GLP-1 drugs and that of other direct-to-consumer companies. They also announced a collaboration where Cost Plus Drugs will be eMed’s distribution partner. The post At SXSW,…
Isaac Health Introduces New Virtual Program to Reduce Dementia Risk
Isaac Health launched an eight-week virtual program to help people reduce dementia risk through lifestyle changes like sleep, nutrition and exercise. The post Isaac Health Introduces New Virtual Program to Reduce Dementia Risk appeared first on MedCity News.
FDA Drug Approval Marks a First for a Disease — But It’s Not Autism
Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence. The post FDA Drug Approval Marks a First for a Disease — But It’s Not Autism appeared first on MedCity…
Epic Is Letting Health Systems Build Their Own Agents — But Are They Ready?
Epic has unveiled its new “agent factory,” a platform that lets health systems build AI agents that are capable of orchestrating entire workflows across the EHR. The post Epic Is Letting Health Systems Build Their Own Agents — But Are They Ready? appeared first on MedCity News.
The Lethal Cost of Regulatory Perfection in Rare Disease
Congress has already granted the FDA flexibility in evaluating therapies for rare diseases, including the use of real-world evidence and natural history data when traditional large-scale trials are not feasible. The question before the FDA now is not if those tools can be applied – they can – but if the agency has the courage…
When Recalls Fail — The Gap Between Notification and Action
For patients, recalls can fail to protect them — not because they came too late, but because they stop at notification and never fully translate into action. The post When Recalls Fail — The Gap Between Notification and Action appeared first on MedCity News.
